Adverse reactions in patients transfused with cryopreserved marrow.
about
Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous systemPreservation of differentiation and clonogenic potential of human hematopoietic stem and progenitor cells during lyophilization and ambient storage.Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.Advancing the preservation of cellular therapy products.Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftmentHematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.Patient care during infusion of hematopoietic progenitor cells.Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservationHas allogeneic stem cell cryopreservation been given the 'cold shoulder'? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation.Preservation of stem cells.Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide.Safe and effective cryopreservation methods for long-term storage of human-amniotic-fluid-derived stem cells.Adverse reactions during stem cell infusion in children treated with autologous and allogeneic stem cell transplantation.Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors.Blood progenitor cells: collection techniques and applications.Transplantation of CD34+ hematopoietic progenitor cells.Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures.Packaging Considerations for BiopreservationContamination of bone marrow transplants from peripheral blood.Cryopreservation of HPCs for clinical use.Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G-CSF support: implications for optimal timing of PBPC harvest.Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells.Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide.Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells.Cryopreserved stem cell products containing dimethyl sulfoxide lead to activation of the coagulation system without any impact on engraftment.Microbial contamination of cord blood stem cells.Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve.Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.DMSO Chemically Alters Cell Membranes to Slow Exocytosis and Increase the Fraction of Partial Transmitter Released.Infusion technique of hematopoietic progenitor cells and related adverse events (CME).Assessing the toxic effects of DMSO on cord blood to determine exposure time limits and the optimum concentration for cryopreservation.Washing of cord blood grafts after thawing: high cell recovery using an automated and closed system.Impact of short-term liquid storage on human CD133(+) stem cells.Optimization of the freezing process for hematopoietic progenitor cells: effect of precooling, initial dimethyl sulfoxide concentration, freezing program, and storage in vapor-phase or liquid nitrogen on in vitro white blood cell quality.
P2860
Q24643257-711B4E2B-477E-4E03-8EDE-77A7F40D2777Q33687124-ADDADBEA-71BB-4253-9187-E360211FCA55Q33819877-FC626A61-8C30-49FE-BD50-3F8BE8B86134Q34072295-EF9B3B55-D7E9-4DE4-8F48-FE06D4247C80Q35475882-507C9FFD-B378-4213-8811-3D7C91E44CA7Q35571628-F2056992-5D36-4C9E-BE14-262719950221Q35780569-BA360A5D-EBBA-4E34-B073-0F4529D1AFC5Q35992742-8442961F-72F5-43C9-AF87-725B237F222FQ36557968-3964DF43-8EBC-4EDA-ABF5-0F3FA209786CQ37666673-7482AAFF-1BD0-46FE-86EB-C8ACB75A4ED9Q37851868-2D72085D-AFD3-446F-A93F-146C584972D2Q38914169-21FC2AD3-0EDE-4CFE-8CE3-039932090113Q40122835-8F26F257-F346-4796-AF9D-C73C8FF0B49EQ40150595-FFDBF4FF-AFAF-4338-A43D-81C15B472314Q40673200-D2746917-9529-40D9-AAC9-4774CEF4C4A2Q40955853-523D1973-704C-41D1-BE4B-568DBDFE1588Q42129681-D7ADD08D-BBBF-4A92-A63D-B9A0BEE059FCQ42177319-B7FD580D-9F6E-4F9A-8883-7AC2338C6D40Q42604087-3C7AEAA4-5053-4BE7-860B-9390BBE7EF27Q43603137-0BECC5FE-7510-4412-B9C1-C02BC056DFE6Q43603150-82AADF57-2B0A-4AFE-B729-6A9E5717F1FFQ44243065-6B43B957-3738-46AC-AB5F-4C30FB6AFDB5Q44856276-942535CD-8432-4117-82F2-5987710B1E18Q45001840-0B8BE0C0-2B96-4D26-9255-D6DA680D14A0Q45336903-B2970C7B-3CBC-4A19-8090-CBE80702D30CQ45713916-0EFFC328-967B-467D-9A1B-E4EAD8092A24Q45868221-9173E2FB-BD91-4EA6-8EF0-F68F9CFACCDAQ46734866-7ADBCBDE-F361-46E0-BC68-4737957B83B0Q46734868-1EE2E803-F014-4FAC-9735-BB48548269FDQ46863074-E282FD64-5F5A-4E34-8B2C-A75FF0DC4B95Q47295009-693AA925-9FDC-41E0-97A4-6AF65C0BFE20Q47763037-26C553C9-2CFB-4A70-8F29-B0CB9FA25CA8Q47889395-90591746-994A-4A53-839C-273566991A85Q48197629-65C3EBC5-6D3E-4116-A0ED-75AF5410F710Q48511715-CF30B8AB-D44F-45F7-BCAD-95757567C6C3Q51737319-F16DAB34-4D57-4642-AD34-166209F1C426Q53028580-E6A21E8D-140A-4966-8D3E-32C95AAF67AF
P2860
Adverse reactions in patients transfused with cryopreserved marrow.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Adverse reactions in patients transfused with cryopreserved marrow.
@en
type
label
Adverse reactions in patients transfused with cryopreserved marrow.
@en
prefLabel
Adverse reactions in patients transfused with cryopreserved marrow.
@en
P2093
P1433
P1476
Adverse reactions in patients transfused with cryopreserved marrow.
@en
P2093
P304
P356
10.1046/J.1537-2995.1991.31691306250.X
P577
1991-07-01T00:00:00Z